ACN - 101321555 Australasian Human Research Ethics Consultancy Services Pty Ltd (AHRECS)

Resource Library

Research Ethics MonthlyAbout Us

ResourcesMerit and integrity

Australasian Human Research Ethics Consultancy Services Pty Ltd (AHRECS)

Personality and fatal diseases: Revisiting a scientific scandal (Papers: Anthony J Pelosi | February 2019)0

Posted by Admin in on October 14, 2019
 

Abstract
During the 1980s and 1990s, Hans J Eysenck conducted a programme of research into the causes, prevention and treatment of fatal diseases in collaboration with one of his protégés, Ronald Grossarth-Maticek. This led to what must be the most astonishing series of findings ever published in the peer-reviewed scientific literature with effect sizes that have never otherwise been encounterered in biomedical research. This article outlines just some of these reported findings and signposts readers to extremely serious scientific and ethical criticisms that were published almost three decades ago. Confidential internal documents that have become available as a result of litigation against tobacco companies provide additional insights into this work. It is suggested that this research programme has led to one of the worst scientific scandals of all time. A call is made for a long overdue formal inquiry.

Keywords
cancer epidemiology, personality and cancer, personality and heart disease, research ethics, research misconduct

Pelosi, A. J. (2019). Personality and fatal diseases: Revisiting a scientific scandal. Journal of Health Psychology, 24(4), 421–439. https://doi.org/10.1177/1359105318822045
Publisher (Open Access): https://journals.sagepub.com/doi/10.1177/1359105318822045

Work of renowned UK psychologist Hans Eysenck ruled ‘unsafe’ – The Guardian (Sarah Boseley | October 2019)0

Posted by Admin in on October 14, 2019
 

Eysenck’s ‘cancer-prone’ personality theory had come under criticism for decades

The work of one of the most famous and influential British psychologists of all time, Hans Eysenck, is under a cloud following an investigation by King’s College London, which has found 26 of his published papers “unsafe”.

King’s says the results and conclusions of the papers “were not considered scientifically rigorous” by its committee of inquiry. Prof Sir Robert Lechler, the provost at King’s, has contacted the editors of the 11 journals where the papers appeared, recommending they should be retracted.

Eysenck, who died in 1997, published prolifically and wrote many well-known books, holding controversial views on a number of subjects, including race and IQ. The investigation centred on research that claimed personality played a bigger part in people’s chances of dying from cancer or heart disease than smoking.

Read the rest of this discussion piece

(Australia) Unauthorised survey asked students to rate Chinese people out of seven – Sydney Morning Herald (Nick Bonyhady | September 2019)0

Posted by Admin in on October 13, 2019
 

An unauthorised survey delivered to students at the University of Sydney under the university’s official logo asked them to rate the attractiveness and intelligence of Chinese people out of seven.

It is interesting this story doesn’t mention the National Statement (2007 updated 2018), the Australian Code (2018) or research misconduct though this may be encapsulated by the reference to suspension and investigation. The reported questions raise concerns as to the merit of the work, respect, justice and the troubling spectre of the alt-right.

The survey was delivered by both paid and volunteer pollsters to students voting in student representative council elections at the university this week. It claimed to be “approved in principle by the University of Sydney’s ethics committee” and “endorsed by the political science department.”
.

A University of Sydney spokeswoman said the university had “very strong concerns” about the content of the survey, which it was not aware of until contacted by the Herald on Wednesday, and how it was delivered.
.

“An initial inquiry indicates ethics approval was not obtained for the study and our logo has been used without permission,” the spokeswoman said. “We are formally contacting the staff and student involved today to advise them the matter may be subject to disciplinary proceedings.”
.

Read the rest of this news story

How to Boost Racial, Ethnic and Gender Diversity in Clinical Research (Report – Syneos: September 2019)0

Posted by Admin in on October 6, 2019
 

Why All Stakeholders Must OWN The Mission
Healthcare transformations take time—and the time lag has consequences.

While this item and the accompanying report are decidedly US-centric, the issues are fundamental and global.  AHRECS Consultant Nik Zeps will be part of a panel discussion at the clinical oncology meeting in Adelaide in November 2019 debating this for the Cancer Council Victoria.

It has been 25 years since Congress passed the National Institutes of Health Revitalization Act requiring federally funded clinical research programs to prioritize inclusion of women and minorities. Since then, both the NIH and the Food and Drug Administration have mounted numerous initiatives, including regulatory guidance aimed at shoring up the law’s intent.
,

Despite parallel efforts by biopharmaceutical innovators, the demographics of clinical trials today still do not reflect the racial, ethnic or gender diversity of target patient populations around the world. This is true for trial subjects, of whom an estimated 83 percent are white. And it’s true for the race/ethnicity/gender representation of investigators at many trial sites as well.

As advanced health systems around the world enter an era of genomic and precision medicine, lack of diversity across the clinical research landscape is a daunting obstacle.

Access this discussion piece and report

0